Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis

European Journal of Neurology

Volumn 22, Issue 2, 2015, Pages 328-333

  Sundal, C ^a,b   Baker, M ^c   Karrenbauer, V ^d   Gustavsen, M ^e   Bedri, S ^d   Glaser, A ^d   Myhr, K M ^b,f   Haugarvoll, K ^b   Zetterberg, H ^a,g   Harbo, H ^e   Kockum, I ^d   Hillert, J ^d   Wszolek, Z ^c   Rademakers, R ^c   Andersen, O ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c MAYO CLINIC   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF OSLO   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Hereditary diffuse leukoencephalopathy with spheroids; White matter lesions

Indexed keywords

BETA1A INTERFERON; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR 1 RECEPTOR; COLONY STIMULATING FACTOR RECEPTOR; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CEREBELLUM DISEASE; CEREBROSPINAL FLUID EXAMINATION; COHORT ANALYSIS; DISEASE COURSE; EXON; FAMILY HISTORY; GENE MUTATION; GENE SEQUENCE; HEREDITARY DIFFUSE LEUKOENCEPHALOPATHY WITH SPHEROID; HUMAN; LEUKOENCEPHALOPATHY; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MEMORY DISORDER; MENTAL DETERIORATION; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NORWEGIAN (CITIZEN); NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; SIBLING; SWEDISH CITIZEN; WHITE MATTER LESION; ADULT; FEMALE; GENETICS; LEUKOENCEPHALOPATHIES; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MUTATION; NORWAY; REGISTER; SWEDEN;

ADULT; EXONS; FEMALE; HUMANS; LEUKOENCEPHALOPATHIES; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MUTATION; NORWAY; PEDIGREE; PHENOTYPE; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; REGISTRIES; SIBLINGS; SWEDEN;

EID: 84920582792     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12572     Document Type: Article

References (27)

1. Rademakers R, Baker M, Nicholson AM, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet 2011; 44: 200-205.
2. Axelsson R, Roytta M, Sourander P, Akesson HO, Andersen O. Hereditary diffuse leucoencephalopathy with spheroids. Acta Psychiatr Scand Suppl 1984; 314: 1-65.
3. Sundal C, Ekholm S, Nordborg C, et al. Update of the original HDLS kindred: divergent clinical courses. Acta Neurol Scand 2012; 126: 67-75.
4. Sundal C, Fujioka S, Van Gerpen JA, et al. Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism Relat Disord 2013; 19: 869-877.
5. Kondo Y, Kinoshita M, Fukushima K, Yoshida K, Ikeda S. Early involvement of the corpus callosum in a patient with hereditary diffuse leukoencephalopathy with spheroids carrying the de novo K793T mutation of CSF1R. Intern Med 2013; 52: 503-506.
6. Sundal C, Wszolek Z. CSF1R-related hereditary diffuse leukoencephalopathy with spheroids. In: Pagon RA, Adam MP, Ardinger HH, et al., eds. GeneReviews(R). Seattle, WA: University of Washington, 2012: 1993-2014.
7. Ahmed R, Guerreiro R, Rohrer JD, et al. A novel A781V mutation in the CSF1R gene causes hereditary diffuse leucoencephalopathy with axonal spheroids. J Neurol Sci 2013; 332: 141-144.
8. Battisti C, Di Donato I, Bianchi S, et al. Hereditary diffuse leukoencephalopathy with axonal spheroids: three patients with stroke-like presentation carrying new mutations in the CSF1R gene. J Neurol 2014; 261: 768-772.
9. Inui T, Kawarai T, Fujita K, et al. A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis. J Neurol Sci 2013; 334: 192-195.
10. Terasawa Y, Osaki Y, Kawarai T, et al. Increasing and persistent DWI changes in a patient with hereditary diffuse leukoencephalopathy with spheroids. J Neurol Sci 2013; 335: 213-215.
11. Karle KN, Biskup S, Schule R, et al. De novo mutations in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). Neurology 2013; 81: 2039-2044.
12. Guerreiro R, Kara E, Le Ber I, et al. Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene. JAMA Neurol 2013; 70: 875-882.
13. Saitoh BY, Yamasaki R, Hayashi S, et al. A case of hereditary diffuse leukoencephalopathy with axonal spheroids caused by a de novo mutation in CSF1R masquerading as primary progressive multiple sclerosis. Mult Scler 2013; 19: 1367-1370.
14. Sundal C, Lash J, Aasly J, et al. Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity. J Neurol Sci 2012; 314: 130-137.
15. Sadovnick AD, Traboulsee AL, Lee JD, Ross JP, Bernales CQ, Vilarino-Guell C. Colony stimulation factor 1 receptor (CSF1R) is not a common cause of multiple sclerosis. Eur J Neurol 2013; 20: e115-e116.
16. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292-302.
17. Sundal C, Van Gerpen JA, Nicholson AM, et al. MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology 2012; 79: 566-574.
18. Skoog B, Runmarker B, Winblad S, Ekholm S, Andersen O. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy. Brain 2012; 135: 900-911.
19. Oksenberg JR. Decoding multiple sclerosis: an update on genomics and future directions. Expert Rev Neurother 2013; 13: 11-19.
20. Beecham AH, Patsopoulos NA, Xifara DK, et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353-1360.
21. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285.
22. Stadelmann C. Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications. Curr Opin Neurol 2011; 24: 224-229.
23. Benarroch EE. Microglia: multiple roles in surveillance, circuit shaping, and response to injury. Neurology 2013; 81: 1079-1088.
24. Mattsson N, Blennow K, Zetterberg H. CSF biomarkers: pinpointing Alzheimer pathogenesis. Ann N Y Acad Sci 2009; 1180: 28-35.
25. Olsson B, Zetterberg H, Hampel H, Blennow K. Biomarker-based dissection of neurodegenerative diseases. Prog Neurobiol 2011; 95: 520-534.
26. van der Knaap M, Valk J. Magnetic Resonance of Myelination and Myelin Disorders, 3rd edn. New York: Springer, 2005.
27. Kohlschutter A, Bley A, Brockmann K, et al. Leukodystrophies and other genetic metabolic leukoencephalopathies in children and adults. Brain Dev 2010; 32: 82-89.